Genetics Institute Inc., of Cambridge, Mass., has appointed ThomasDesRosier vice president and chief patent counsel.Robertson, Stephens and Co., of San Francisco, has appointed EdwardHurwitz a vice president and senior research analyst in biotechnology.GeneMedicine Inc., of Houston, has appointed Kathryn Stankis vicepresident, administration and human resources.CytRx Corp., of Norcross, Ga., has appointed Richard Shuler presidentand CEO of its VetLife Inc. subsidiary.Cygnus Therapeutic Systems, of Redwood City, Calif., has appointedNeil Ackerman vice president, research and development.IMRE Corp., of Seattle, has named Franco Quagliata senior vicepresident and chief medical officer, and Joseph Balint vice president,research and development.Sanguine Corp., of Pasadena, Calif., has appointed John Stavich vicepresident and technical director in charge of production.Cohesive Biotechnologies Inc., of Acton, Mass., has appointed HubertQuinn president and CEO.Aprogenex Inc., of Houston, has named Peter Carbonaro director ofoperations and Michael G. Rusnak director of marketing.EDITEK Inc., of Burlington, N.C., has appointed Michael Terretti vicepresident and general manager of its Princeton Diagnostic Laboratoriesof America Inc. subsidiary.

(c) 1997 American Health Consultants. All rights reserved.